Zinc‐α2‐glycoprotein relieved seizure‐Induced neuronal glucose uptake impairment via insulin‐like growth factor 1 receptor‐regulated glucose transporter 3 expression

Abstract Glucose hypometabolism is observed in epilepsy and promotes epileptogenesis. Glucose hypometabolism in epilepsy may be attributed to decreased neuronal glucose uptake, but its molecular mechanism remains unclear. Zinc‐α2‐glycoprotein (ZAG) is related to glucose metabolism and is reported to suppress seizures. The anti‐epileptic effect of ZAG may be attributed to its regulation of neuronal glucose metabolism. This study explored the effect of ZAG on neuronal glucose uptake and its molecular mechanism via insulin‐like growth factor 1 receptor (IGF1R)‐regulated glucose transporter 3 (GLUT‐3) expression. The ZAG level was modulated by lentivirus in primary culture neurons. Neuronal seizure models were induced by Mg 2+ ‐free artificial cerebrospinal fluid. We assessed neuronal glucose uptake by the 2‐NBDG method and Glucose Uptake Colorimetric Assay Kit. IGF1R was activated by IGF1 and blocked by AXL1717. The expression and distribution of IGF1R and GLUT‐3, together with IGF1R phosphorylation, were measured by western blot. The binding between ZAG and IGF1R was determined by coimmunoprecipitation. Neuronal glucose uptake and GLUT‐3 expression were significantly decreased by seizure or ZAG knockdown, whereas ZAG over‐expression or IGF1 treatment reversed this decrease. The effect of ZAG on neuronal glucose uptake and GLUT‐3 expression was blocked by AXL1717. ZAG increased IGF1R distribution and phosphorylation possibly by binding. Additionally, IGF1R increased GLUT‐3 activity by increasing GLUT‐3 expression. In epilepsy/seizure, neuronal glucose uptake suppression may be attributed to a decrease in ZAG, which suppresses neuronal GLUT‐3 expression by regulating the activity of IGF1R. ZAG, IGF1R, and GLUT‐3 may be novel potential therapeutic targets of glucose hypometabolism in epilepsy and seizures. image